JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Studenberg, S. D.
Right arrow Articles by Brouwer, K. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Studenberg, S. D.
Right arrow Articles by Brouwer, K. L.

Impaired biliary excretion of acetaminophen glucuronide in the isolated perfused rat liver after acute phenobarbital treatment and in vivo phenobarbital pretreatment

SD Studenberg and KL Brouwer

Division of Pharmaceutics, School of Pharmacy, University of North Carolina, Chapel Hill.

The influence of phenobarbital (PB) on the hepatobiliary disposition of acetaminophen (APAP), acetaminophen glucuronide (AG) and acetaminophen sulfate (AS) was examined in the recirculating isolated perfused rat liver (IPL). PB was administered as a 5-mumol bolus to the IPL (acute) or in vivo (75 mg/kg/day, i.p., x 5 days), followed by a 48-hr washout, before addition of an APAP (66-mumol) bolus to the IPL. Acute PB administration to the IPL did not affect the total hepatic clearance of APAP or the formation clearance to AG and AS. The rate constant for the biliary excretion of AG and the percentage of the dose recovered in bile as AG were decreased significantly after the acute PB dose. In vivo PB pretreatment induced significantly the UDP- glucuronyltransferases (i.e., an increase in APAP clearance, the formation clearance to AG and in the estimate of the AG formation rate constant). The estimate of the AG sinusoidal egress rate constant after in vivo PB pretreatment also was increased significantly. The AG biliary excretion rate constant and the percentage of the dose recovered in bile as AG were decreased approximately 5-fold after in vivo PB pretreatment, similar to values obtained after acute PB administration. PB was detected only after acute PB administration, whereas unconjugated p-hydroxyphenobarbital was not detected after either treatment. These data indicate that neither PB itself nor an induction effect related to in vivo PB pretreatment are required directly to impair hepatobiliary disposition.

Volume 261, Issue 3, pp. 1022-1027, 06/01/1992
Copyright © 1992 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
M. J. Zamek-Gliszczynski, K. A. Hoffmaster, X. Tian, R. Zhao, J. W. Polli, J. E. Humphreys, L. O. Webster, A. S. Bridges, J. C. Kalvass, and K. L. R. Brouwer
MULTIPLE MECHANISMS ARE INVOLVED IN THE BILIARY EXCRETION OF ACETAMINOPHEN SULFATE IN THE RAT: ROLE OF MRP2 AND BCRP1
Drug Metab. Dispos., August 1, 2005; 33(8): 1158 - 1165.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
P. Chandra, B. M. Johnson, P. Zhang, G. M. Pollack, and K. L. R. Brouwer
MODULATION OF HEPATIC CANALICULAR OR BASOLATERAL TRANSPORT PROTEINS ALTERS HEPATOBILIARY DISPOSITION OF A MODEL ORGANIC ANION IN THE ISOLATED PERFUSED RAT LIVER
Drug Metab. Dispos., August 1, 2005; 33(8): 1238 - 1243.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
N. J. Patel, M. J. Zamek-Gliszczynski, P. Zhang, Y.-H. Han, P. L. M. Jansen, P. J. Meier, B. Stieger, and K. L. R. Brouwer
Phenobarbital Alters Hepatic Mrp2 Function by Direct and Indirect Interactions
Mol. Pharmacol., July 1, 2003; 64(1): 154 - 159.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
W. Kang and M. Weiss
Modeling the Metabolism of Idarubicin to Idarubicinol in Rat Heart: Effect of Rutin and Phenobarbital
Drug Metab. Dispos., April 1, 2003; 31(4): 462 - 468.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
H. Xiong, H. Suzuki, Y. Sugiyama, P. J. Meier, G. M. Pollack, and K. L. R. Brouwer
Mechanisms of Impaired Biliary Excretion of Acetaminophen Glucuronide after Acute Phenobarbital Treatment or Phenobarbital Pretreatment
Drug Metab. Dispos., September 1, 2002; 30(9): 962 - 969.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
H. Xiong, K. Yoshinari, K. L. R. Brouwer, and M. Negishi
Role of Constitutive Androstane Receptor in the In Vivo Induction of Mrp3 and CYP2B1/2 by Phenobarbital
Drug Metab. Dispos., August 1, 2002; 30(8): 918 - 923.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
D. R. Johnson and C. D. Klaassen
Regulation of Rat Multidrug Resistance Protein 2 by Classes of Prototypical Microsomal Enzyme Inducers That Activate Distinct Transcription Pathways
Toxicol. Sci., June 1, 2002; 67(2): 182 - 189.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
H. Xiong, K. C. Turner, E. S. Ward, P. L. M. Jansen, and K. L. R. Brouwer
Altered Hepatobiliary Disposition of Acetaminophen Glucuronide in Isolated Perfused Livers from Multidrug Resistance-Associated Protein 2-Deficient TR- Rats
J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 512 - 518.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1992 by the American Society for Pharmacology and Experimental Therapeutics.